Health technology leader Philips recognized as Clarivate Top 100 Global Innovator
06 Marzo 2024 - 3:00AM
Health technology leader Philips recognized as Clarivate Top 100
Global Innovator
March 6, 2024
Company’s innovative products and solutions improved the lives
of 1.9 billion people in 2023
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, has
been included in the 2024 Clarivate Top 100 Global Innovator™ list.
Philips’ global R&D programs and collaborations aim to deliver
personal health solutions for consumers and professional health
solutions for healthcare providers and their patients in the
hospital and the home. Together with healthcare providers and other
ecosystem partners, Philips co-creates innovations that increase
access to healthcare globally and create sustainable and resilient
healthcare models.
For example, illustrating the global reach of its efforts to
accelerate more productive and sustainable MR imaging operations,
Philips has installed more than 1,000 MR systems with its virtually
helium-free BlueSeal magnet, which requires only 0.5% of the helium
of a conventional Philips MR system. Additionally, Philips recently
launched its new Azurion image-guided therapy system and advanced
informatics to enhance the minimally invasive diagnosis and
treatment of neurovascular patients and reduce the time clinicians
require per patient.
Roy Jakobs, CEO of Royal Philips said: “At Philips, we’ve been
innovating to improve lives for over 130 years. People’s needs are
at the very heart of how we innovate and design for sustainable
impact with a ‘safety and quality first’ mindset. Innovation is our
core strength and will continue to be our core differentiator.
Recent industry trends have accelerated the adoption of technology
within healthcare. We are embracing these trends and shifting our
innovation to a more patient- and people-centric model closer to
our customers.”
Further examples of innovations that help clinicians increase
productivity and save time include Philips’ recently introduced
next-generation EPIQ Elite and Affiniti ultrasound systems with AI
and expanded tele-ultrasound capability, and Philips’ recently
launched Philips HealthSuite Imaging, a cloud-based Picture
Archiving and Communication System with high-speed remote access
for diagnostic reading and AI-enabled workflow orchestration.
The Top 100 Global Innovators uses a comparative analysis of
global invention data to assess the strength of every patented
idea, using measures tied directly to their innovative power.
Philips has now been included in this reputable list for eleven
consecutive years and is the highest ranked company in the ‘Medical
and biotechnology’ industry in the 2024 report. The full report can
be found here.
For further information, please
contact:
Ben ZwirsPhilips External RelationsTel.: +31 6 1521 3446E-mail:
ben.zwirs@philips.com
About Royal PhilipsRoyal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people's health and well-being through meaningful
innovation. Philips’ patient- and people-centric innovation
leverages advanced technology and deep clinical and consumer
insights to deliver personal health solutions for consumers and
professional health solutions for healthcare providers and their
patients in the hospital and the home. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging,
ultrasound, image-guided therapy, monitoring, and enterprise
informatics, as well as in personal health. Philips generated 2023
sales of EUR 18.2 billion and employs approximately 69,700
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- Azurion neuro biplane
- Philips BlueSeal MRI Magnet
- Philips HealthSuite Imaging
- EPIQ Elite ultrasound system
Koninklijke Philips NV (EU:PHIA)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Koninklijke Philips NV (EU:PHIA)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
